Korian: valuation
What the market value assumes, and what the company's own statements and its peers' prices would put it at. Every assumption is yours to change.
Cash-flow value
Fewer than two of the last three years have both cash from operations and capital spending on file.
Your own DCF model
A full discounted-cash-flow model of Korian, started from its filings: revenue growth and margins year by year, bear, base and bull cases, the WACC and its parts, sensitivity tables and a value per share against the dated market price. Save it, share it with your team or by a read-only link.
Open the DCF modelAgainst the industry Medical Care Facilities
Multiples of its companies with a market value at most 60 days old, times Korian's own figures of FY2025.
| Multiple | Peers (25th / median / 75th) | Korian | Applied to | Value (25th to 75th) | Companies |
|---|---|---|---|---|---|
| P/E | 15.0× / 24.5× / 68.2× | — | net income $2 M | $27 M to $123 M | 28 |
| Price to sales | 0.8× / 1.3× / 2.7× | — | revenue $6.0 B | $4.8 B to $15.9 B | 36 |
| Price to book | 2.7× / 3.8× / 8.0× | — | book equity $4.6 B | $12.3 B to $36.5 B | 28 |
The statements it starts from
USD millions at each year's exchange rate; free cash flow = cash from operations less capital spending.
| Fiscal year | Revenue | Net income | Cash from operations | Capital spending | Free cash flow | Net debt | Source |
|---|---|---|---|---|---|---|---|
| FY2025to Dec 31, 2025 | $6.0 B | $2 M | $1.2 B | — | — | — | ESEF annual report |
| FY2024to Dec 31, 2024 | $5.7 B | $-60 M | $983 M | — | — | — | ESEF annual report |
| FY2023to Dec 31, 2023 | — | — | — | — | — | — | ESEF annual report |
| FY2022to Dec 31, 2022 | — | — | — | — | — | — | ESEF annual report |